There is a young maverick CEO under the real pressures of business in reality.
My questions would have been far harder and precise. You have all the things in place as you have pointed out, but you need to make cash flows quickly or gain a capital investment from some avenue of these partnerships, or you face real financial concerns. Can you assure investors of some pending cash flows that would address the obvious investor and valid business concerns as reflected in your drastically falling share price?
It is absolutely a far better prospect now than in 2019 with 7 vs 1 IP protections, around 5 times the revenues, and 25 vs 10 geographical sales locations, the coming partnerships and US cranial sales. But investors clearly wanted to hear about their more pressing concerns about cash flows and the cash balance, because the revenues in absolute terms are insignificant to its admittedly tightly run costs. I just don't think that webinar was ever the forum for that listening to the other presentations.
But he is clearly aware of those concerns in his ending comments (particularly his Temasek mention) and answers to questions that came from investors like yourself on Hot Copper.
I am a very recent investor and just feel this company silly valuation at $10 million given its potential and recent pending partnership announcements. Get how long-term investors must be utterly dejected however.
- Forums
- ASX - By Stock
- OSX
- Ann: Investor Webinar Presentation
OSX
osteopore limited
Add to My Watchlist
0.00%
!
1.0¢

Ann: Investor Webinar Presentation, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.830M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.0¢ | $33.27K | 2.901M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 3031165 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 305868 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 1841165 | 0.010 |
12 | 1672765 | 0.009 |
3 | 500000 | 0.008 |
3 | 542857 | 0.007 |
1 | 200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 305868 | 2 |
0.014 | 38500 | 1 |
0.015 | 572510 | 2 |
0.016 | 684274 | 2 |
0.017 | 135555 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online